retatrutide triple hormone receptor agonist obesity mechanism of action Action: Explained – Bolt Pharmacy Retatrutide: A Triple Agonist Shaping
Description
Waist circumference, hip circumference, and limb measurements often change even during scale plateaus as body composition shifts
The standard titration increases the dose every four weeks, with 5 mg serving as the minimum maintenance dose and 15 mg the maximum used in obesity trials
This lessens the likelihood of eating past the point of fullness and/or comfort
Energy levels may shift
SGLT2i-preceding group, n = 224)
